Results 11 to 20 of about 338,921 (264)
Hypertensive Pulmonary Vascular Disease [PDF]
Patients with pulmonary artery blood pressures that are chronically elevated to levels of the order of the systemic blood pressures, form a distinct clinicopathologic entity. This condition may complicate a ventricular septal defect, Eisenmenger's complex, patent ductus arteriosus, atrial septal defect, and mitral stenosis, and it may occur as ...
D, HEATH, W, WHITAKER
openaire +2 more sources
Malignant ventricular arrhythmias (VA) after acute myocardial infarction remain a major threat. Aim of this study was to characterize the electrophysiological and autonomic sequelae of cardiac ischemia and reperfusion (I/R) in mice during the first week ...
Lukas Clasen +8 more
doaj +1 more source
Background: Many anticoagulant strategies are available for the extended treatment of venous thromboembolism, yet little guidance exists regarding which drug is most effective and safe.
Zhiqiang Liu +4 more
doaj +1 more source
Background Balloon pulmonary angioplasty (BPA) has been demonstrated to improve cardiac function and exercise capacity in patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH), but its instant impact on cardiopulmonary function ...
Qi Jin +12 more
doaj +1 more source
Takotsubo syndrome with pulmonary embolism: a case report and literature review
Background Takotsubo syndrome (TTS) is an acute cardiac condition with reversible heart failure which is often triggered by psychological and physical stressful events.
Qi Jin +7 more
doaj +1 more source
Targeted therapy in pulmonary veno-occlusive disease: time for a rethink?
Background Pulmonary veno-occlusive disease (PVOD) is a rare condition with poor prognosis, and lung transplantation is recommended as the only curative therapy.
Qin Luo +8 more
doaj +1 more source
ObjectiveTo explore the comparative clinical efficacy and safety outcomes of anticoagulation before (pre-) or following (post-) thrombolytic therapy in systemic thrombolytic therapy for pulmonary embolism (PE).MethodsPubMed, the Cochrane Library, EMBASE,
Jiang-Shan Tan +9 more
doaj +1 more source
BackgroundFew published studies have evaluated the power of the oxygen uptake efficiency slope (OUES) to predict outcomes in patients with idiopathic pulmonary arterial hypertension (IPAH), who typically die of right‐sided heart failure. Our study sought
Yi Tang +9 more
doaj +1 more source
Objective Obstructive sleep apnoea (OSA) is one cause of pulmonary hypertension (PH) and can also emerge along with PH. The clinical diagnosis and treatment of OSA in patients with PH are still controversial.
Lu Yan +8 more
doaj +1 more source
Pulmonary Vascular Diseases [PDF]
The pulmonary circulation has fascinated researchers and clinicians for more than a century. Romberg first described the pathology of human pulmonary arterial hypertension (PAH) in 1891. In 1946, Euler and Liljestrand described the hypoxic pulmonary vasoconstriction: Whereas hypoxia dilates most systemic vascular beds, it constricts the pulmonary ...
Evangelos D. Michelakis +1 more
openaire +1 more source

